Literature DB >> 3225334

Campylobacter pylori: clinical, histological, and serological studies.

C Musgrove1, F J Bolton, A M Krypczyk, J M Temperley, S A Cairns, W G Owen, D N Hutchinson.   

Abstract

The presence of Campylobacter pylori, histologically diagnosed gastritis, and antibodies to C pylori were determined in a series of 113 patients undergoing endoscopy. Paired biopsy specimens from the fundus, body, and antrum were collected from 59 patients and from the antrum of 54 patients. The presence of C pylori was confirmed by either culture or silver stain in 30 of 59, 31 of 59, and 54 of 103 biopsy specimens from the fundus, body, and antrum, respectively. Of the specimens which contained C pylori 20 of 30 (66%) from the fundus, 25 of 31 (80%) from the body, and 54 (100%) from the antrum showed gastritis. C pylori and gastritis were shown in seven of nine (78.1%) of patients with gastric ulcers and in nine of 11 (82%) of patients with duodenal ulcers. Using an enzyme linked immunosorbent assay (ELISA) technique to detect IgG antibody to C pylori, all patients with histologically diagnosed gastritis and organisms present had titres of greater than or equal to 640; eight of 39 (21%) of patients without gastritis and without organisms gave similar titres. Hence the presence of C pylori was associated with gastritis and with raised titres of IgG antibody.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3225334      PMCID: PMC1141767          DOI: 10.1136/jcp.41.12.1316

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

2.  Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy.

Authors:  L Booth; G Holdstock; H MacBride; P Hawtin; J R Gibson; A Ireland; J Bamforth; C E DuBoulay; R S Lloyd; A D Pearson
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

3.  Gastric spiral bacteria.

Authors: 
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

4.  Immune response to Campylobacter pyloridis.

Authors:  B J Rathbone; J I Wyatt; B W Worsley; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

5.  Spiral organisms in endoscopic biopsies of the human stomach.

Authors:  T P Rollason; J Stone; J M Rhodes
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

6.  Pyloric CLO in the human stomach.

Authors:  J R Lambert; K L Dunn; E R Eaves; M G Korman; J Hansky; K J Pinkard
Journal:  Med J Aust       Date:  1985-08-19       Impact factor: 7.738

7.  Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies.

Authors:  D M Jones; A M Lessells; J Eldridge
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

8.  Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa.

Authors:  C S Goodwin; E D Blincow; J R Warren; T E Waters; C R Sanderson; L Easton
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

9.  Pyloric Campylobacter infection and gastroduodenal disease.

Authors:  B J Marshall; D B McGechie; P A Rogers; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

10.  Isolation from gastric epithelium of Campylobacter-like bacteria that are distinct from "Campylobacter pyloridis".

Authors:  G Kasper; N Dickgiesser
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

View more
  14 in total

Review 1.  How labile is gastric infection with H pylori?

Authors:  M Hobsley; F-I Tovey; J Holton
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

2.  Inoculation of barrier-born pigs with Helicobacter pylori: a useful animal model for gastritis type B.

Authors:  L Engstrand; S Gustavsson; A Jörgensen; A Schwan; A Scheynius
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Evaluation of three Campylobacter pylori antigen preparations for screening sera from patients undergoing endoscopy.

Authors:  F J Bolton; D N Hutchinson
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

4.  Comparison of ELISA antigen preparations alone or in combination for serodiagnosing Helicobacter pylori infections.

Authors:  A M Hirschl; B J Rathbone; J I Wyatt; J Berger; M L Rotter
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

5.  Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations.

Authors:  K Nagata; T Mizuta; Y Tonokatu; Y Fukuda; H Okamura; T Hayashi; T Shimoyama; T Tamura
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  Evaluation of a commercial latex test for serological diagnosis of Helicobacter pylori infection in treated and untreated patients.

Authors:  A M Hirschl; M M Hirschl; J Berger; M L Rotter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

7.  Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis.

Authors:  K Henriksson; A Uribe; B Sandstedt; C E Nord
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

8.  Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection.

Authors:  H Goossens; Y Glupczynski; A Burette; C Van den Borre; J P Butzler
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

9.  Prevalence of Helicobacter pylori infection in infants and family contacts in a poor Bangladesh community.

Authors:  S A Sarker; M M Rahman; D Mahalanabis; P K Bardhan; P Hildebrand; C Beglinger; K Gyr
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

10.  Antral Helicobacter pylori in patients with chronic renal failure.

Authors:  S Shousha; A H Arnaout; S H Abbas; R A Parkins
Journal:  J Clin Pathol       Date:  1990-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.